Showing 1 - 8 results of 8 for search 'Sanjeev Banerjee', query time: 0.04s Refine Results
  1. 1
    Histone deacetylase inhibitors induce epithelial-to-mesenchymal transition in prostate cancer cells.

    Histone deacetylase inhibitors induce epithelial-to-mesenchymal transition in prostate cancer cells. by Dejuan Kong, Aamir Ahmad, Bin Bao, Yiwei Li, Sanjeev Banerjee, Fazlul H Sarkar

    Published 2012-01-01
    Get full text
    Article
  2. 2
    DNA polymerase β as a novel target for chemotherapeutic intervention of colorectal cancer.

    DNA polymerase β as a novel target for chemotherapeutic intervention of colorectal cancer. by Aruna S Jaiswal, Sanjeev Banerjee, Ritu Aneja, Fazlul H Sarkar, David A Ostrov, Satya Narayan

    Published 2011-02-01
    Get full text
    Article
  3. 3
    Activation of AMP-activated protein kinase by 3,3'-Diindolylmethane (DIM) is associated with human prostate cancer cell death in vitro and in vivo.

    Activation of AMP-activated protein kinase by 3,3'-Diindolylmethane (DIM) is associated with human prostate cancer cell death in vitro and in vivo. by Di Chen, Sanjeev Banerjee, Qiuzhi C Cui, Dejuan Kong, Fazlul H Sarkar, Q Ping Dou

    Published 2012-01-01
    Get full text
    Article
  4. 4
    Pan-Bcl-2 inhibitor AT-101 enhances tumor cell killing by EGFR targeted T cells.

    Pan-Bcl-2 inhibitor AT-101 enhances tumor cell killing by EGFR targeted T cells. by Archana Thakur, Lawrence G Lum, Dana Schalk, Asfar Azmi, Sanjeev Banerjee, Fazlul H Sarkar, Ramzi Mohommad

    Published 2012-01-01
    Get full text
    Article
  5. 5
    Hypoxia induced aggressiveness of prostate cancer cells is linked with deregulated expression of VEGF, IL-6 and miRNAs that are attenuated by CDF.

    Hypoxia induced aggressiveness of prostate cancer cells is linked with deregulated expression of VEGF, IL-6 and miRNAs that are attenuated by CDF. by Bin Bao, Aamir Ahmad, Dejuan Kong, Shadan Ali, Asfar S Azmi, Yiwei Li, Sanjeev Banerjee, Subhash Padhye, Fazlul H Sarkar

    Published 2012-01-01
    Get full text
    Article
  6. 6
    Anti-tumor activity of a novel compound-CDF is mediated by regulating miR-21, miR-200, and PTEN in pancreatic cancer.

    Anti-tumor activity of a novel compound-CDF is mediated by regulating miR-21, miR-200, and PTEN in pancreatic cancer. by Bin Bao, Shadan Ali, Dejuan Kong, Sanila H Sarkar, Zhiwei Wang, Sanjeev Banerjee, Amro Aboukameel, Subhash Padhye, Philip A Philip, Fazlul H Sarkar

    Published 2011-03-01
    Get full text
    Article
  7. 7
    Hypoxia-induced aggressiveness of pancreatic cancer cells is due to increased expression of VEGF, IL-6 and miR-21, which can be attenuated by CDF treatment.

    Hypoxia-induced aggressiveness of pancreatic cancer cells is due to increased expression of VEGF, IL-6 and miR-21, which can be attenuated by CDF treatment. by Bin Bao, Shadan Ali, Aamir Ahmad, Asfar S Azmi, Yiwei Li, Sanjeev Banerjee, Dejuan Kong, Seema Sethi, Amro Aboukameel, Subhash B Padhye, Fazlul H Sarkar

    Published 2012-01-01
    Get full text
    Article
  8. 8
    Activated K-ras and INK4a/Arf deficiency cooperate during the development of pancreatic cancer by activation of Notch and NF-κB signaling pathways.

    Activated K-ras and INK4a/Arf deficiency cooperate during the development of pancreatic cancer by activation of Notch and NF-κB signaling pathways. by Zhiwei Wang, Sanjeev Banerjee, Aamir Ahmad, Yiwei Li, Asfar S Azmi, Jason R Gunn, Dejuan Kong, Bin Bao, Shadan Ali, Jiankun Gao, Ramzi M Mohammad, Lucio Miele, Murray Korc, Fazlul H Sarkar

    Published 2011-01-01
    Get full text
    Article

Search Tools: